Agustina Alaimo

1.2k citations
30 papers · 910 indexed · h-index 17
Topics
Retinal Diseases and Treatments (8 papers)Mitochondrial Function and Pathology (5 papers)Alzheimer's disease research and treatments (5 papers)

In The Last Decade

Agustina Alaimo

30 papers receiving 905 citations

Peers

Agustina Alaimo
Comparison fields: 5 of 96
  • Molecular Biology 328
  • Physiology 175
  • Epidemiology 142
  • Ophthalmology 125
  • Neurology 121
Replace Fei Fei with:
Fei Fei China
Cheong‐Meng Chong Macao
Roxana Mayra Gorojod Argentina
Ewa Kucharska Poland
Joo‐Hyun Shin South Korea
Mengfei Chen China
Peter Dimitrion United States
Federica Pessina Italy
Francesca Lazzara Italy
Xuan Zou China
Agustina Alaimo relative to Fei Fei China Fei Fei's profile →
Citations per field
00.5×
Fei Fei · 1×
Citations per year

Countries citing papers authored by Agustina Alaimo

Since Specialization
Citations

This map shows the geographic impact of Agustina Alaimo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agustina Alaimo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agustina Alaimo more than expected).

Fields of papers citing papers by Agustina Alaimo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agustina Alaimo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agustina Alaimo. The network helps show where Agustina Alaimo may publish in the future.

Co-authorship network of co-authors of Agustina Alaimo

This figure shows the co-authorship network connecting the top 25 collaborators of Agustina Alaimo. A scholar is included among the top collaborators of Agustina Alaimo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agustina Alaimo. Agustina Alaimo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 2
3 2
4 6
5 5
6 13
7 6
8 16
9 8
10 28
11 12
12 83
13 27
14 43
15 18
16 31
17 17
18 64
19 72
20 49

About Agustina Alaimo

Agustina Alaimo is a scholar working on Ophthalmology, Geriatrics and Gerontology and Pharmaceutical Science, having authored 30 papers that have together received 910 indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (8 papers), Mitochondrial Function and Pathology (5 papers) and Alzheimer's disease research and treatments (5 papers). The work is most often cited by research in Neurology (121 citations), Ophthalmology (125 citations) and Pharmaceutical Science (53 citations). Agustina Alaimo has collaborated with scholars based in Argentina, United States and Uruguay. Frequent co-authors include Roxana Mayra Gorojod, Mónica L. Kotler, Flavia Saravia, Soledad Porte Alcón, Oscar E. Pérez, Ana Paula Domínguez Rubio, Juan Beauquis, Carlos Pomilio, Jimena H. Martínez and Guadalupe García Liñares. Their work appears in journals such as PLoS ONE, Free Radical Biology and Medicine and Frontiers in Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026